Novel Multi-Drug Resistant Organisms
Local and national surveillance has identified novel forms of multi-drug resistant organisms (MDROs) that need to be detected and contained before they spread. Many of these organisms are difficult to treat, have been associated with international travel, and have the potential to spread rapidly.
Healthcare facilities and laboratories should
any of the following organisms are detected the Acute Communicable Disease Control Program within 1 working day:
Candida auris (such as echinocandin-or pan-resistant cases)
- Non-KPC-carbapenemase-producing Enterobacterales
- Carbapenemase-producing Acinetobacter
- Carbapenemase-producing Pseudomonas aeruginosa
- Pan-resistant organisms
CDC guidance to are further categorize these into four tiers based on their local epidemiology and clinical significance, which can be reviewed in our
LACDPH MDRO Containment Tiers. Tier 1 and Tier 2 organisms warrant additional investigation from LACDPH staff to prevent the spread of these concerning organisms as much as possible. For example, when a Tier 2 organism is identified,
screening should be performed to detect and contain any other cases. Additional guidance is coming soon!
Monthly MDRO Lab Newsletter
CDC Containment Strategy Responding to Emerging AR